F1RefidQuick AuthorAuthorTitlePublication DatePeriodicalF8VolumeF10IssueF12Page Start-EndGroupF15Publication DataConditionCondition (to hide)Outcome Measurescleaned up resultsOutcome Measures_Total ParticipantsQuality Assignment (SIGN 50)AbstractKeywordsPowerPower1Provider TypeIntervention Description: Number Assigned (Dropout Rate)# Assigned (Dropout Rate)_double check # assignIntervention Description: DosagesIntervention Description: Dosages1*Meta-AnalysisRelevant Results _ConclusionsAdverse EventsPubMed Link
21 1290 Guarda-Nardini, 2012* L. Guarda-Nardini, A. Stecco, C. Stecco, S. Masiero and D. Manfredini Myofascial pain of the jaw muscles: comparison of short-term effectiveness of botulinum toxin injections and fascial manipulation technique 2012 CRANIO: The Journal of Craniomandibular & Sleep Practice vol 30 vol 30 2 pages 95-102 Group 1 pages 95-102 CRANIO: The Journal of Craniomandibular & Sleep Practice, vol 30: 2, pages 95-102 Musculoskeletal Pain: Myofascial pain of the jaw muscles 30a (8M/22F) participants with myofascial pain of the jaw muscles (mean age of 45 ± 14.1) Visual Analog Scale (maximum pain level) Jaw Range of Motion (Range of Motion) Pain: Visual Analog Scale; Activity: Jaw Range of Motion. 30 2-Acceptable A randomized controlled trial was performed to compare the short-term effectiveness of botulinum toxin injections and physiatric treatment provided by means of Fascial Manipulation techniques in the management of myofascial pain of jaw muscles. Thirty patients with a Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) diagnosis of myofascial pain were randomized to receive either single-session botulinum toxin injections (Group A) or multiple-session Fascial Manipulation (Group B). Maximum pain levels (VAS ratings) and jaw range of motion in millimeters (maximum mouth opening protrusion right and left laterotrusion) were assessed at baseline at the end of treatment and at a three-month follow-up. Both treatment protocols provided significant improvement over time for pain symptoms. The two treatments seem to be almost equally effective Fascial Manipulation being slightly superior to reduce subjective pain perception and botulinum toxin injections being slightly superior to increase jaw range of motion. Differences between the two treatment protocols as to changes in the outcome parameters at the three-months follow-up were not relevant clinically. Findings from the present investigation are in line with literature data supporting the effectiveness of a wide spectrum of conservative treatment approaches to myofascial pain of the jaw muscles. Future studies on larger samples over a longer follow-up span are needed on the way to identify tailored treatment strategies. Botulinum Toxins -- Therapeutic Use Yes, power achieved Yes, Power analysis based on published literature data on patient populations recruited at the same clinic (20) and assuming a mean value VAS value of 6/10 +/- 3/10 in the main outcome variable, viz., pain levels, revealed that the study design was able t Operator (type not specified) Fascial Manipulation Technique: 15 (0%); Botulinum Toxin Injection (Active Control): 15 (0%). 15 (0%); 15 (0%). Fascial Manipulation Technique: 2-4 x 50 mins, 1x/w, 2-4w + ND; Botulinum Toxin Injection (Active Control): ND x few min (exact min ND), ND, ND + ND. 2-4 x 50 mins, 1x/w, 2-4w + ND; ND x few min (exact min ND), ND, ND + ND. Yes *Visual Analog Scale (maximum pain level): p = Not Described, Effect Size = -1.00, Active Control, pre / post; Jaw Range of Motion (Range of Motion): p < 0.01 (between groups) over time. Massage effective for: Activity. "no relevant side effects were detected in any patients, with the exception of some minor discomfort during chewing reported by the injected patients in the first two-to-three weeks after treatment and of some pain with digital pressure of Center of Coord http://www.ncbi.nlm.nih.gov/pubmed/?term=guarda+Myofascial+pain+of+the+jaw+muscles%3A+comparison+of+short-term+effectiveness+of+botulinum+toxin+injections+and+fascial+manipulation+technique
F1 21
Refid 1290
Quick Author Guarda-Nardini, 2012*
Author L. Guarda-Nardini, A. Stecco, C. Stecco, S. Masiero and D. Manfredini
Title Myofascial pain of the jaw muscles: comparison of short-term effectiveness of botulinum toxin injections and fascial manipulation technique
Publication Date 2012
Periodical CRANIO: The Journal of Craniomandibular & Sleep Practice
F8 vol
Volume 30
F10 vol 30
Issue 2
F12 pages
Page Start-End 95-102
Group Group 1
F15 pages 95-102
Publication Data CRANIO: The Journal of Craniomandibular & Sleep Practice, vol 30: 2, pages 95-102
Condition Musculoskeletal Pain: Myofascial pain of the jaw muscles
Condition (to hide) 30a (8M/22F) participants with myofascial pain of the jaw muscles (mean age of 45 ± 14.1)
Outcome Measures
cleaned up results Visual Analog Scale (maximum pain level) Jaw Range of Motion (Range of Motion)
Outcome Measures_ Pain: Visual Analog Scale; Activity: Jaw Range of Motion.
Total Participants 30
Quality Assignment (SIGN 50) 2-Acceptable
Abstract A randomized controlled trial was performed to compare the short-term effectiveness of botulinum toxin injections and physiatric treatment provided by means of Fascial Manipulation techniques in the management of myofascial pain of jaw muscles. Thirty patients with a Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) diagnosis of myofascial pain were randomized to receive either single-session botulinum toxin injections (Group A) or multiple-session Fascial Manipulation (Group B). Maximum pain levels (VAS ratings) and jaw range of motion in millimeters (maximum mouth opening protrusion right and left laterotrusion) were assessed at baseline at the end of treatment and at a three-month follow-up. Both treatment protocols provided significant improvement over time for pain symptoms. The two treatments seem to be almost equally effective Fascial Manipulation being slightly superior to reduce subjective pain perception and botulinum toxin injections being slightly superior to increase jaw range of motion. Differences between the two treatment protocols as to changes in the outcome parameters at the three-months follow-up were not relevant clinically. Findings from the present investigation are in line with literature data supporting the effectiveness of a wide spectrum of conservative treatment approaches to myofascial pain of the jaw muscles. Future studies on larger samples over a longer follow-up span are needed on the way to identify tailored treatment strategies.
Keywords Botulinum Toxins -- Therapeutic Use
Power Yes, power achieved
Power1 Yes, Power analysis based on published literature data on patient populations recruited at the same clinic (20) and assuming a mean value VAS value of 6/10 +/- 3/10 in the main outcome variable, viz., pain levels, revealed that the study design was able t
Provider Type Operator (type not specified)
Intervention Description: Number Assigned (Dropout Rate) Fascial Manipulation Technique: 15 (0%); Botulinum Toxin Injection (Active Control): 15 (0%).
# Assigned (Dropout Rate)_ 15 (0%); 15 (0%).
double check # assign
Intervention Description: Dosages Fascial Manipulation Technique: 2-4 x 50 mins, 1x/w, 2-4w + ND; Botulinum Toxin Injection (Active Control): ND x few min (exact min ND), ND, ND + ND.
Intervention Description: Dosages1 2-4 x 50 mins, 1x/w, 2-4w + ND; ND x few min (exact min ND), ND, ND + ND.
*Meta-Analysis Yes
Relevant Results _ *Visual Analog Scale (maximum pain level): p = Not Described, Effect Size = -1.00, Active Control, pre / post; Jaw Range of Motion (Range of Motion): p < 0.01 (between groups) over time.
Conclusions Massage effective for: Activity.
Adverse Events "no relevant side effects were detected in any patients, with the exception of some minor discomfort during chewing reported by the injected patients in the first two-to-three weeks after treatment and of some pain with digital pressure of Center of Coord
PubMed Link http://www.ncbi.nlm.nih.gov/pubmed/?term=guarda+Myofascial+pain+of+the+jaw+muscles%3A+comparison+of+short-term+effectiveness+of+botulinum+toxin+injections+and+fascial+manipulation+technique
22 1336 Haas, 2010 M. Haas, A. Spegman, D. Peterson, M. Aickin and D. Vavrek Dose response and efficacy of spinal manipulation for chronic cervicogenic headache: a pilot randomized controlled trial 2010 Spine J vol 10 vol 10 2 pages 117-28 Group 2 pages 117-28 Spine J, vol 10: 2, pages 117-28 Headache: Cervicogenic headache 80bc (16M/64F) participants with cervicogenic headache (mean age = 36 ± 11 yrs) Modified Von Korff scales (Cervicogenic headache pain intensity) Modified Von Korff scales (Cervicogenic headache disability) Modified Von Korff scales (neck pain intensity) Modified Von Korff scales (neck disability) Short Form-12 Health Survey Physical Component Score & Mental Component Score (depression) Short Form-12 Health Survey Physical Component Score & Mental Component Score (general health) Number of Cervicogenic headache ____ Number of other headaches____ Pain: Modified Von Korff scales, Number of Cervicogenic headache, Number of other headaches; Activity: Modified Von Korff scales (Cervicogenic headache disability); Mood: Short Form-12 Health Survey Mental Component Score; Quality of Life: Short Form-12 80 2-Acceptable BACKGROUND CONTEXT: Systematic reviews of randomized controlled trials suggest that spinal manipulative therapy (SMT) is efficacious for care of cervicogenic headache (CGH). The effect of SMT dose on outcomes has not been studied. PURPOSE: To compare the efficacy of two doses of SMT and two doses of light massage (LM) for CGH. PATIENT SAMPLE: Eighty patients with chronic CGH. MAIN OUTCOME MEASURES: Modified Von Korff pain and disability scales for CGH and neck pain (minimum clinically important difference=10 on 100-point scale), number of headaches in the last 4 weeks, and medication use. Data were collected every 4 weeks for 24 weeks. The primary outcome was the CGH pain scale. METHODS: Participants were randomized to either 8 or 16 treatment sessions with either SMT or a minimal LM control. Patients were treated once or twice per week for 8 weeks. Adjusted mean differences (AMD) between groups were computed using generalized estimating equations for the longitudinal outcomes over all follow-up time points (profile) and using regression modeling for individual time points with baseline characteristics as covariates and with imputed missing data. RESULTS: For the CGH pain scale, comparisons of 8 and 16 treatment sessions yielded small dose effects: |AMD| Adult No, power not achieved No Chiropractor Light Massage-8 visits: 20 (ND); Light Massage-16 visits: 20 (ND); Spinal Manipulation Therapy-8 visits: 20 (ND); Spinal Manipulation Therapy-16 visits: 20 (ND). 20 (ND); 20 (ND); 20 (ND); 20 (ND). Light Massage-8 visits: 8 x 10 mins, 2x/w, 8w + ND; Light Massage-16 visits: 16 x 10 mins, 2x/w, 8w + ND; Spinal Manipulation Therapy-8 visits: 8 x 12 mins, ND, ND + ND; Spinal Manipulation Therapy-16 visits: 16 x 12 mins, ND, ND + ND. 8 x 10 mins, 2x/w, 8w + ND; 16 x 10 mins, 2x/w, 8w + ND; 8 x 12 mins, ND, ND + ND; 16 x 12 mins, ND, ND + ND. No Modified Von Korff scales (Cervicogenic headache pain intensity): p < 0.05 (between groups) (Spinal Manipulation Therapy/ Light massage) at 12w and 24w; Modified Von Korff scales (Cervicogenic headache disability): p < 0.05 (between groups) (Spinal Manipulation Therapy/ Light massage) at 12w; Modified Von Korff scales (neck pain intensity): p = Not Significant (between groups) (Spinal Manipulation Therapy/ Light massage) at all time points; Modified Von Korff scales (neck disability): p < 0.05 (between groups) (Spinal Manipulation Therapy/ Light massage) at 12w; Short Form-12 Health Survey Physical Component Score & Mental Component Score (depression): p = Not Described; Short Form-12 Health Survey Physical Component Score & Mental Component Score (general health): p = Not Described; Number of Cervicogenic headache: p < 0.05 (between groups) (Spinal Manipulation Therapy/ Light massage) at 12w; Number of other headaches: p < 0.05 (between groups) (Spinal Manipulation Therapy/Light massage) at 24w. No relevant significant results.  Authors do not report or mention anything about AEs http://www.ncbi.nlm.nih.gov/pubmed/?term=haas+Dose+response+and+efficacy+of+spinal+manipulation+for+chronic+cervicogenic+headache%3A+a+pilot+randomized+controlled+trial
F1 22
Refid 1336
Quick Author Haas, 2010
Author M. Haas, A. Spegman, D. Peterson, M. Aickin and D. Vavrek
Title Dose response and efficacy of spinal manipulation for chronic cervicogenic headache: a pilot randomized controlled trial
Publication Date 2010
Periodical Spine J
F8 vol
Volume 10
F10 vol 10
Issue 2
F12 pages
Page Start-End 117-28
Group Group 2
F15 pages 117-28
Publication Data Spine J, vol 10: 2, pages 117-28
Condition Headache: Cervicogenic headache
Condition (to hide) 80bc (16M/64F) participants with cervicogenic headache (mean age = 36 ± 11 yrs)
Outcome Measures
cleaned up results Modified Von Korff scales (Cervicogenic headache pain intensity) Modified Von Korff scales (Cervicogenic headache disability) Modified Von Korff scales (neck pain intensity) Modified Von Korff scales (neck disability) Short Form-12 Health Survey Physical Component Score & Mental Component Score (depression) Short Form-12 Health Survey Physical Component Score & Mental Component Score (general health) Number of Cervicogenic headache ____ Number of other headaches____
Outcome Measures_ Pain: Modified Von Korff scales, Number of Cervicogenic headache, Number of other headaches; Activity: Modified Von Korff scales (Cervicogenic headache disability); Mood: Short Form-12 Health Survey Mental Component Score; Quality of Life: Short Form-12
Total Participants 80
Quality Assignment (SIGN 50) 2-Acceptable
Abstract BACKGROUND CONTEXT: Systematic reviews of randomized controlled trials suggest that spinal manipulative therapy (SMT) is efficacious for care of cervicogenic headache (CGH). The effect of SMT dose on outcomes has not been studied. PURPOSE: To compare the efficacy of two doses of SMT and two doses of light massage (LM) for CGH. PATIENT SAMPLE: Eighty patients with chronic CGH. MAIN OUTCOME MEASURES: Modified Von Korff pain and disability scales for CGH and neck pain (minimum clinically important difference=10 on 100-point scale), number of headaches in the last 4 weeks, and medication use. Data were collected every 4 weeks for 24 weeks. The primary outcome was the CGH pain scale. METHODS: Participants were randomized to either 8 or 16 treatment sessions with either SMT or a minimal LM control. Patients were treated once or twice per week for 8 weeks. Adjusted mean differences (AMD) between groups were computed using generalized estimating equations for the longitudinal outcomes over all follow-up time points (profile) and using regression modeling for individual time points with baseline characteristics as covariates and with imputed missing data. RESULTS: For the CGH pain scale, comparisons of 8 and 16 treatment sessions yielded small dose effects: |AMD|
Keywords Adult
Power No, power not achieved
Power1 No
Provider Type Chiropractor
Intervention Description: Number Assigned (Dropout Rate) Light Massage-8 visits: 20 (ND); Light Massage-16 visits: 20 (ND); Spinal Manipulation Therapy-8 visits: 20 (ND); Spinal Manipulation Therapy-16 visits: 20 (ND).
# Assigned (Dropout Rate)_ 20 (ND); 20 (ND); 20 (ND); 20 (ND).
double check # assign
Intervention Description: Dosages Light Massage-8 visits: 8 x 10 mins, 2x/w, 8w + ND; Light Massage-16 visits: 16 x 10 mins, 2x/w, 8w + ND; Spinal Manipulation Therapy-8 visits: 8 x 12 mins, ND, ND + ND; Spinal Manipulation Therapy-16 visits: 16 x 12 mins, ND, ND + ND.
Intervention Description: Dosages1 8 x 10 mins, 2x/w, 8w + ND; 16 x 10 mins, 2x/w, 8w + ND; 8 x 12 mins, ND, ND + ND; 16 x 12 mins, ND, ND + ND.
*Meta-Analysis No
Relevant Results _ Modified Von Korff scales (Cervicogenic headache pain intensity): p < 0.05 (between groups) (Spinal Manipulation Therapy/ Light massage) at 12w and 24w; Modified Von Korff scales (Cervicogenic headache disability): p < 0.05 (between groups) (Spinal Manipulation Therapy/ Light massage) at 12w; Modified Von Korff scales (neck pain intensity): p = Not Significant (between groups) (Spinal Manipulation Therapy/ Light massage) at all time points; Modified Von Korff scales (neck disability): p < 0.05 (between groups) (Spinal Manipulation Therapy/ Light massage) at 12w; Short Form-12 Health Survey Physical Component Score & Mental Component Score (depression): p = Not Described; Short Form-12 Health Survey Physical Component Score & Mental Component Score (general health): p = Not Described; Number of Cervicogenic headache: p < 0.05 (between groups) (Spinal Manipulation Therapy/ Light massage) at 12w; Number of other headaches: p < 0.05 (between groups) (Spinal Manipulation Therapy/Light massage) at 24w.
Conclusions No relevant significant results. 
Adverse Events Authors do not report or mention anything about AEs
PubMed Link http://www.ncbi.nlm.nih.gov/pubmed/?term=haas+Dose+response+and+efficacy+of+spinal+manipulation+for+chronic+cervicogenic+headache%3A+a+pilot+randomized+controlled+trial
23 1342 Hains, 2010* G. Hains, M. Descarreaux and F. Hains Chronic Shoulder Pain of Myofascial Origin: A Randomized Clinical Trial Using Ischemic Compression Therapy 2010 Journal of Manipulative and Physiological Therapeutics vol 33 vol 33 5 pages 362-369 Group 1 pages 362-369 Journal of Manipulative and Physiological Therapeutics, vol 33: 5, pages 362-369 Musculoskeletal Pain: Chronic shoulder pain 63c (sex ND) participants with chronic shoulder pain (mean age ND) Shoulder Pain and Disability Index (severity of pain and functional impairment of the shoulder) Amelioration Numerical Scale (patient's perceived improvement) Pain: Shoulder Pain and Disability Index; Quality of Life: Amelioration Numerical Scale. 63 2-Acceptable Objective: The aim of this clinical trial was to evaluate the effect of 15 myofascial therapy treatments using ischemic compression on shoulder trigger points in patients with chronic shoulder pain. Methods: Forty-one patients received 15 experimental treatments which consisted of ischemic compressions on trigger points located in the supraspinatus muscle the infraspinatus muscle the deltoid muscle and the biceps tendon. Eighteen patients received the control treatment involving 15 ischemic compression treatments of trigger points located in cervical and upper thoracic areas. Of the 18 patients forming the control group 16 went on to receive 15 experimental treatments after having received their initial control treatments. Outcome measures included a validated 13-question questionnaire measuring shoulder pain and functional impairment. A second questionnaire was used to assess patients'' perceived amelioration using a scale from 0% to 100%. Outcome measure evaluation was completed for both groups at baseline after 15 treatments 30 days after the last treatment and finally for the experimental group only 6 months later. Results: A significant group null time interval interaction was observed after the first 15 treatments indicating that the experimental group had a significant reduction in their Shoulder Pain and Disability Index (SPADI) score compared with the control group (62% vs 18% amelioration). Moreover the patients perceived percentages of amelioration were higher in the experimental group after 15 treatments (75% vs 29%). Finally the control group subjects significantly reduced their SPADI scores after crossover (55%). Conclusion: The results of this study suggest that myofascial therapy using ischemic compression on shoulder trigger points may reduce the symptoms of patients experiencing chronic shoulder pain. (copyright) 2010 National University of Health Sciences. Adult Not Described ND Chiropractor Myofascial Release: ND (ND); Sham: ND (ND). ND (ND); ND (ND). Myofascial Release: 15 x ND, 3x/w, ND + ND; Sham: ND. 15 x ND, 3x/w, ND + ND; ND. Yes *Shoulder Pain and Disability Index (severity of pain and functional impairment of the shoulder): p < 0.001 (within groups) (Myofascial Release) at 6 mos, p = 0.003 (between groups) at first 15 treatments, Effect Size = -0.19, Sham, pre / post; Amelioration Numerical Scale (patient's perceived improvement): p < 0.001 (between groups) over time. Massage effective for: Pain, Quality of Life. Authors report NO AEs occurred http://www.ncbi.nlm.nih.gov/pubmed/?term=hains+Chronic+Shoulder+Pain+of+Myofascial+Origin%3A+A+Randomized+Clinical+Trial+Using+Ischemic+Compression+Therapy
F1 23
Refid 1342
Quick Author Hains, 2010*
Author G. Hains, M. Descarreaux and F. Hains
Title Chronic Shoulder Pain of Myofascial Origin: A Randomized Clinical Trial Using Ischemic Compression Therapy
Publication Date 2010
Periodical Journal of Manipulative and Physiological Therapeutics
F8 vol
Volume 33
F10 vol 33
Issue 5
F12 pages
Page Start-End 362-369
Group Group 1
F15 pages 362-369
Publication Data Journal of Manipulative and Physiological Therapeutics, vol 33: 5, pages 362-369
Condition Musculoskeletal Pain: Chronic shoulder pain
Condition (to hide) 63c (sex ND) participants with chronic shoulder pain (mean age ND)
Outcome Measures
cleaned up results Shoulder Pain and Disability Index (severity of pain and functional impairment of the shoulder) Amelioration Numerical Scale (patient's perceived improvement)
Outcome Measures_ Pain: Shoulder Pain and Disability Index; Quality of Life: Amelioration Numerical Scale.
Total Participants 63
Quality Assignment (SIGN 50) 2-Acceptable
Abstract Objective: The aim of this clinical trial was to evaluate the effect of 15 myofascial therapy treatments using ischemic compression on shoulder trigger points in patients with chronic shoulder pain. Methods: Forty-one patients received 15 experimental treatments which consisted of ischemic compressions on trigger points located in the supraspinatus muscle the infraspinatus muscle the deltoid muscle and the biceps tendon. Eighteen patients received the control treatment involving 15 ischemic compression treatments of trigger points located in cervical and upper thoracic areas. Of the 18 patients forming the control group 16 went on to receive 15 experimental treatments after having received their initial control treatments. Outcome measures included a validated 13-question questionnaire measuring shoulder pain and functional impairment. A second questionnaire was used to assess patients'' perceived amelioration using a scale from 0% to 100%. Outcome measure evaluation was completed for both groups at baseline after 15 treatments 30 days after the last treatment and finally for the experimental group only 6 months later. Results: A significant group null time interval interaction was observed after the first 15 treatments indicating that the experimental group had a significant reduction in their Shoulder Pain and Disability Index (SPADI) score compared with the control group (62% vs 18% amelioration). Moreover the patients perceived percentages of amelioration were higher in the experimental group after 15 treatments (75% vs 29%). Finally the control group subjects significantly reduced their SPADI scores after crossover (55%). Conclusion: The results of this study suggest that myofascial therapy using ischemic compression on shoulder trigger points may reduce the symptoms of patients experiencing chronic shoulder pain. (copyright) 2010 National University of Health Sciences.
Keywords Adult
Power Not Described
Power1 ND
Provider Type Chiropractor
Intervention Description: Number Assigned (Dropout Rate) Myofascial Release: ND (ND); Sham: ND (ND).
# Assigned (Dropout Rate)_ ND (ND); ND (ND).
double check # assign
Intervention Description: Dosages Myofascial Release: 15 x ND, 3x/w, ND + ND; Sham: ND.
Intervention Description: Dosages1 15 x ND, 3x/w, ND + ND; ND.
*Meta-Analysis Yes
Relevant Results _ *Shoulder Pain and Disability Index (severity of pain and functional impairment of the shoulder): p < 0.001 (within groups) (Myofascial Release) at 6 mos, p = 0.003 (between groups) at first 15 treatments, Effect Size = -0.19, Sham, pre / post; Amelioration Numerical Scale (patient's perceived improvement): p < 0.001 (between groups) over time.
Conclusions Massage effective for: Pain, Quality of Life.
Adverse Events Authors report NO AEs occurred
PubMed Link http://www.ncbi.nlm.nih.gov/pubmed/?term=hains+Chronic+Shoulder+Pain+of+Myofascial+Origin%3A+A+Randomized+Clinical+Trial+Using+Ischemic+Compression+Therapy
24 1343 Hains, 2010 G. Hains and F. Hains Patellofemoral pain syndrome managed by ischemic compression to the trigger points located in the peri-patellar and retro-patellar areas: A randomized clinical trial 2010 Clinical Chiropractic vol 13 vol 13 3 pages 201-209 Group 1 pages 201-209 Clinical Chiropractic, vol 13: 3, pages 201-209 Musculoskeletal Pain: Patellofemoral pain syndrome 38bc (10M/28F) participants with patellofemoral pain syndrome (mean age = 25.2 yrs) Visual Analog Scale (pain) Patellar-grinding Test (pain) Pain: Visual Analog Scale, Patellar-grinding Test. 38 1-High Design A prospective, randomized controlled trial with cross-over. Background Patellofemoral pain syndrome is one of the most common causes of knee pain. Its prevalence is relatively high in adolescents and younger adults. However, very few clinical trials have investigated the different therapeutic approaches commonly used in its clinical management. Objective To measure the efficacy of myofascial manual therapy (ischemic compression) directly to the knee for chronic patellofemoral pain syndrome. Methods The experimental group (N = 27) received 15 sessions of manual ischemic compression applied to peri-patellar and retro-patellar regions. The control group (N = 11) received 15 sessions of manual ischemic compression on trigger points over the hip muscles. After 30 days of follow-up, the control group was offered the opportunity to receive the study intervention. Changes in pain intensity were assessed in both groups using a visual analog pain scale and a 5-point scale to monitor the patient's response to the patellar-grinding test. Outcomes were compared between groups using two-way repeated measures ANOVA whereas one-way repeated measures ANOVA were used to test for the main effect of time intervals. Results The experimental group showed a significant (p < 0.05) reduction in pain that was maintained at 30 days (from 5.97 ± 0.32 to 3.4 ± 0.45) and 6 months (from 5.97 ± 0.32 to 3.5 ± 0.53). Patellar-grinding scores improved only in the experimental group (from 3.4 ± 0.13 to 1.2 ± 0.19). Conclusion A treatment regimen with 15 sessions of manual ischemic compression applied to peri-patellar and retro-patellar regions of the knee was found to be effective in short and medium term at reducing symptoms of patellofemoral syndrome for up to 6 months. Patellofemoral Pain Syndrome -- Therapy No, power not achieved No Examiner Ischemic Compression on peri-patellar and retro-patellar regions / Ischemic Compression on trigger point over hip muscles: 38 (8%) (Crossover) Ischemic Compression on peri-patellar and retro-patellar regions: 15 x ND, 3x/w, ND + ND; Ischemic Compression on trigger point over hip muscles: 15 x ND, 3x/w, ND + ND. 15 x ND, 3x/w, ND + ND; 15 x ND, 3x/w, ND + ND. No Visual Analog Scale (pain): p < 0.05 (within groups) (Ischemic Compression on peri-patellar and retro-patellar regions) at 30d and 6 mos FU; Patellar-grinding Test (pain): p = Not Described. Massage effective for: Pain. Authors do not report or mention anything about AEs Not in PubMed
F1 24
Refid 1343
Quick Author Hains, 2010
Author G. Hains and F. Hains
Title Patellofemoral pain syndrome managed by ischemic compression to the trigger points located in the peri-patellar and retro-patellar areas: A randomized clinical trial
Publication Date 2010
Periodical Clinical Chiropractic
F8 vol
Volume 13
F10 vol 13
Issue 3
F12 pages
Page Start-End 201-209
Group Group 1
F15 pages 201-209
Publication Data Clinical Chiropractic, vol 13: 3, pages 201-209
Condition Musculoskeletal Pain: Patellofemoral pain syndrome
Condition (to hide) 38bc (10M/28F) participants with patellofemoral pain syndrome (mean age = 25.2 yrs)
Outcome Measures
cleaned up results Visual Analog Scale (pain) Patellar-grinding Test (pain)
Outcome Measures_ Pain: Visual Analog Scale, Patellar-grinding Test.
Total Participants 38
Quality Assignment (SIGN 50) 1-High
Abstract Design A prospective, randomized controlled trial with cross-over. Background Patellofemoral pain syndrome is one of the most common causes of knee pain. Its prevalence is relatively high in adolescents and younger adults. However, very few clinical trials have investigated the different therapeutic approaches commonly used in its clinical management. Objective To measure the efficacy of myofascial manual therapy (ischemic compression) directly to the knee for chronic patellofemoral pain syndrome. Methods The experimental group (N = 27) received 15 sessions of manual ischemic compression applied to peri-patellar and retro-patellar regions. The control group (N = 11) received 15 sessions of manual ischemic compression on trigger points over the hip muscles. After 30 days of follow-up, the control group was offered the opportunity to receive the study intervention. Changes in pain intensity were assessed in both groups using a visual analog pain scale and a 5-point scale to monitor the patient's response to the patellar-grinding test. Outcomes were compared between groups using two-way repeated measures ANOVA whereas one-way repeated measures ANOVA were used to test for the main effect of time intervals. Results The experimental group showed a significant (p < 0.05) reduction in pain that was maintained at 30 days (from 5.97 ± 0.32 to 3.4 ± 0.45) and 6 months (from 5.97 ± 0.32 to 3.5 ± 0.53). Patellar-grinding scores improved only in the experimental group (from 3.4 ± 0.13 to 1.2 ± 0.19). Conclusion A treatment regimen with 15 sessions of manual ischemic compression applied to peri-patellar and retro-patellar regions of the knee was found to be effective in short and medium term at reducing symptoms of patellofemoral syndrome for up to 6 months.
Keywords Patellofemoral Pain Syndrome -- Therapy
Power No, power not achieved
Power1 No
Provider Type Examiner
Intervention Description: Number Assigned (Dropout Rate) Ischemic Compression on peri-patellar and retro-patellar regions / Ischemic Compression on trigger point over hip muscles: 38 (8%) (Crossover)
# Assigned (Dropout Rate)_
double check # assign
Intervention Description: Dosages Ischemic Compression on peri-patellar and retro-patellar regions: 15 x ND, 3x/w, ND + ND; Ischemic Compression on trigger point over hip muscles: 15 x ND, 3x/w, ND + ND.
Intervention Description: Dosages1 15 x ND, 3x/w, ND + ND; 15 x ND, 3x/w, ND + ND.
*Meta-Analysis No
Relevant Results _ Visual Analog Scale (pain): p < 0.05 (within groups) (Ischemic Compression on peri-patellar and retro-patellar regions) at 30d and 6 mos FU; Patellar-grinding Test (pain): p = Not Described.
Conclusions Massage effective for: Pain.
Adverse Events Authors do not report or mention anything about AEs
PubMed Link Not in PubMed
25 1363 Han, 2006 S. H. Han, M. H. Hur, J. Buckle, J. Choi and M. S. Lee Effect of aromatherapy on symptoms of dysmenorrhea in college students: A randomized placebo-controlled clinical trial 2006 J Altern Complement Med vol 12 vol 12 6 pages 535-41 Group 3 pages 535-41 J Altern Complement Med, vol 12: 6, pages 535-41 Visceral Pain: Menstrual cramps and symptoms of dysmenorrhea 67c females with menstrual cramps and symptoms of dysmenorrhea (mean age = 20 ± 1.2 yrs) Visual Analog Scale (pain intensity) Severity of Dysmenorrea (pain severity) Pain: Visual Analog Scale; Severity of Dysmenorrea. 67 1-High OBJECTIVE: The purpose of this study was to explore the effect of aromatherapy on menstrual cramps and symptoms of dysmenorrhea. DESIGN: The study was a randomized placebo-controlled trial. SUBJECTS: The subjects were 67 female college students who rated their menstrual cramps to be greater than 6 on a 10-point visual analogue scale who had no systemic or reproductive diseases and who did not use contraceptive drugs. INTERVENTION: Subjects were randomized into three groups: (1) an experimental group (n = 25) who received aromatherapy (2) a placebo group (n = 20) and (3) a control group (n = 22). Aromatherapy was applied topically to the experimental group in the form of an abdominal massage using two drops of lavender (Lavandula officinalis) one drop of clary sage (Salvia sclarea) and one drop of rose (Rosa centifolia) in 5 cc of almond oil. The placebo group received the same treatment but with almond oil only and the control group received no treatment. OUTCOME MEASURES: The menstrual cramps levels was assessed using a visual analogue scale and severity of dysmenorrhea was measured with a verbal multidimensional scoring system. RESULTS: The menstrual cramps were significantly lowered in the aromatherapy group than in the other two groups at both post-test time points (first and second day of menstruation after treatment). From the multiple regression aromatherapy was found to be associated with the changes in menstrual cramp levels (first day: Beta = -2.48 95% CI: -3.68 to -1.29 p < 0.001; second day: Beta = -1.97 95% CI: -3.66 to -0.29 p = 0.02 and the severity of dysmenorrhea (first day: Beta = 0.31 95% CI: 0.05 to 0.57 p = 0.02; second day: Beta = 0.33 95% CI: 0.10 to 0.56 p = 0.006) than that found in the other two groups. CONCLUSIONS: These findings suggest that aromatherapy using topically applied lavender clary sage and rose is effective in decreasing the severity of menstrual cramps. Aromatherapy can be offered as part of the nursing care to women experiencing menstrual cramps or dysmenorrhea. Adult Not Described ND Masseur Massage with aromatherapy in almond oil: 25 (0%); Massage with almond oil: 20 (0%); No treatment: 22 (0%). 25 (0%); 20 (0%); 22 (0%). Massage with aromatherapy in almond oil: 7 x 15 mins, 1x/d, 7d + ND; Massage with almond oil: ND x 15 mins, ND, ND + ND; No treatment: ND. 7 x 15 mins, 1x/d, 7d + ND; ND x 15 mins, ND, ND + ND; ND. No Visual Analog Scale (pain intensity): p < 0.001 (within groups) (aromatherapy) at all time points, p = Not Significant (within groups) at 1d, p < 0.05 at 2d (placebo), p = Not Significant (within groups) (placebo) at all time points; Severity of Dysmenorrea (pain severity): p < 0.02 (between groups) (aromatherapy / Control), p = Not Significant (between groups) (placebo / Control) at all time points. Massage effective for: Pain. Authors do not report or mention anything about AEs http://www.ncbi.nlm.nih.gov/pubmed/?term=han+Effect+of+aromatherapy+on+symptoms+of+dysmenorrhea+in+college+students%3A+A+randomized+placebo-controlled+clinical+trial
F1 25
Refid 1363
Quick Author Han, 2006
Author S. H. Han, M. H. Hur, J. Buckle, J. Choi and M. S. Lee
Title Effect of aromatherapy on symptoms of dysmenorrhea in college students: A randomized placebo-controlled clinical trial
Publication Date 2006
Periodical J Altern Complement Med
F8 vol
Volume 12
F10 vol 12
Issue 6
F12 pages
Page Start-End 535-41
Group Group 3
F15 pages 535-41
Publication Data J Altern Complement Med, vol 12: 6, pages 535-41
Condition Visceral Pain: Menstrual cramps and symptoms of dysmenorrhea
Condition (to hide) 67c females with menstrual cramps and symptoms of dysmenorrhea (mean age = 20 ± 1.2 yrs)
Outcome Measures
cleaned up results Visual Analog Scale (pain intensity) Severity of Dysmenorrea (pain severity)
Outcome Measures_ Pain: Visual Analog Scale; Severity of Dysmenorrea.
Total Participants 67
Quality Assignment (SIGN 50) 1-High
Abstract OBJECTIVE: The purpose of this study was to explore the effect of aromatherapy on menstrual cramps and symptoms of dysmenorrhea. DESIGN: The study was a randomized placebo-controlled trial. SUBJECTS: The subjects were 67 female college students who rated their menstrual cramps to be greater than 6 on a 10-point visual analogue scale who had no systemic or reproductive diseases and who did not use contraceptive drugs. INTERVENTION: Subjects were randomized into three groups: (1) an experimental group (n = 25) who received aromatherapy (2) a placebo group (n = 20) and (3) a control group (n = 22). Aromatherapy was applied topically to the experimental group in the form of an abdominal massage using two drops of lavender (Lavandula officinalis) one drop of clary sage (Salvia sclarea) and one drop of rose (Rosa centifolia) in 5 cc of almond oil. The placebo group received the same treatment but with almond oil only and the control group received no treatment. OUTCOME MEASURES: The menstrual cramps levels was assessed using a visual analogue scale and severity of dysmenorrhea was measured with a verbal multidimensional scoring system. RESULTS: The menstrual cramps were significantly lowered in the aromatherapy group than in the other two groups at both post-test time points (first and second day of menstruation after treatment). From the multiple regression aromatherapy was found to be associated with the changes in menstrual cramp levels (first day: Beta = -2.48 95% CI: -3.68 to -1.29 p < 0.001; second day: Beta = -1.97 95% CI: -3.66 to -0.29 p = 0.02 and the severity of dysmenorrhea (first day: Beta = 0.31 95% CI: 0.05 to 0.57 p = 0.02; second day: Beta = 0.33 95% CI: 0.10 to 0.56 p = 0.006) than that found in the other two groups. CONCLUSIONS: These findings suggest that aromatherapy using topically applied lavender clary sage and rose is effective in decreasing the severity of menstrual cramps. Aromatherapy can be offered as part of the nursing care to women experiencing menstrual cramps or dysmenorrhea.
Keywords Adult
Power Not Described
Power1 ND
Provider Type Masseur
Intervention Description: Number Assigned (Dropout Rate) Massage with aromatherapy in almond oil: 25 (0%); Massage with almond oil: 20 (0%); No treatment: 22 (0%).
# Assigned (Dropout Rate)_ 25 (0%); 20 (0%); 22 (0%).
double check # assign
Intervention Description: Dosages Massage with aromatherapy in almond oil: 7 x 15 mins, 1x/d, 7d + ND; Massage with almond oil: ND x 15 mins, ND, ND + ND; No treatment: ND.
Intervention Description: Dosages1 7 x 15 mins, 1x/d, 7d + ND; ND x 15 mins, ND, ND + ND; ND.
*Meta-Analysis No
Relevant Results _ Visual Analog Scale (pain intensity): p < 0.001 (within groups) (aromatherapy) at all time points, p = Not Significant (within groups) at 1d, p < 0.05 at 2d (placebo), p = Not Significant (within groups) (placebo) at all time points; Severity of Dysmenorrea (pain severity): p < 0.02 (between groups) (aromatherapy / Control), p = Not Significant (between groups) (placebo / Control) at all time points.
Conclusions Massage effective for: Pain.
Adverse Events Authors do not report or mention anything about AEs
PubMed Link http://www.ncbi.nlm.nih.gov/pubmed/?term=han+Effect+of+aromatherapy+on+symptoms+of+dysmenorrhea+in+college+students%3A+A+randomized+placebo-controlled+clinical+trial
26 1390 Hasson, 2004* D. Hasson, B. Arnetz, L. Jelveus and B. Edelstam A Randomized Clinical Trial of the Treatment Effects of Massage Compared to Relaxation Tape Recordings on Diffuse Long-Term Pain 2004 Psychotherapy and Psychosomatics vol 73 vol 73 1 pages 17-24 Group 1 pages 17-24 Psychotherapy and Psychosomatics, vol 73: 1, pages 17-24 Musculoskeletal Pain: Diffuse and long-term musculoskeletal pain 129ac (sex = ND) participants with diffuse and long-term musculoskeletal pain (mean age = ND) Muscle Pain Scale (pain) Mental Energy Scale (mental and cognitive well-being) Pain: Muscle Pain Scale; Quality of Life: Mental Energy Scale. 129 2-Acceptable Long-term musculoskeletal pain is a common problem in primary health care settings that is difficult to treat. Two common treatments are mental relaxation and massage. Scientific studies show contradictory results. Many studies lack long-term follow-up even though it is a chronic disorder. The purpose of this randomized clinical trial was to assess possible effects of massage as compared to listening to relaxation tapes in conditions of ''diffuse'' and long-term musculoskeletal pain. 129 patients from primary health care suffering from long-term musculoskeletal pain were randomized to either a massage or mental relaxation group and assessed before during and after treatment. During treatment there was a significant improvement in the three main outcome measures: self-rated health mental energy and muscle pain only in the massage group as compared to the relaxation group. However at the 3-month post-treatment follow-up there was a significant worsening in the outcome measures back to initial rating levels in the massage group as compared to no changes in the relaxation group. Massage but not mental relaxation is beneficial in attenuating diffuse musculoskeletal symptoms. Beneficial effects were registered only during treatment. (PsycINFO Database Record (c) 2012 APA all rights reserved) Mental relaxation Yes, power achieved Yes, using mental energy and muscle pain scales as outcome measures, the sample yielded a ß of 0.10 (Power.90), using an alpha of 0.05, for detecting a 15% difference between study groups. Physiotherapist Massage: ND (ND); Mental relaxation (Active Control): ND (ND). ND (ND); ND (ND). Massage: 6-10 x 30 mins, 1-3x/w, ND + ND; Mental relaxation (Active Control): ND x ND, 2x/w, 5w + ND. 6-10 x 30 mins, 1-3x/w, ND + ND; ND x ND, 2x/w, 5w + ND. Yes *Muscle Pain Scale (pain): p < 0.01 (between groups) over time, Effect Size = 0.48, Active Control, pre / post; Mental Energy Scale (mental and cognitive well-being): p < 0.01 (between groups) over time; Self-rated Health (health status): p < 0.03 (between groups) over time. Massage effective for: Pain, Quality of Life. Authors do not report or mention anything about AEs http://www.ncbi.nlm.nih.gov/pubmed/?term=hasson+A+Randomized+Clinical+Trial+of+the+Treatment+Effects+of+Massage+Compared+to+Relaxation+Tape+Recordings+on+Diffuse+Long-Term+Pain
F1 26
Refid 1390
Quick Author Hasson, 2004*
Author D. Hasson, B. Arnetz, L. Jelveus and B. Edelstam
Title A Randomized Clinical Trial of the Treatment Effects of Massage Compared to Relaxation Tape Recordings on Diffuse Long-Term Pain
Publication Date 2004
Periodical Psychotherapy and Psychosomatics
F8 vol
Volume 73
F10 vol 73
Issue 1
F12 pages
Page Start-End 17-24
Group Group 1
F15 pages 17-24
Publication Data Psychotherapy and Psychosomatics, vol 73: 1, pages 17-24
Condition Musculoskeletal Pain: Diffuse and long-term musculoskeletal pain
Condition (to hide) 129ac (sex = ND) participants with diffuse and long-term musculoskeletal pain (mean age = ND)
Outcome Measures
cleaned up results Muscle Pain Scale (pain) Mental Energy Scale (mental and cognitive well-being)
Outcome Measures_ Pain: Muscle Pain Scale; Quality of Life: Mental Energy Scale.
Total Participants 129
Quality Assignment (SIGN 50) 2-Acceptable
Abstract Long-term musculoskeletal pain is a common problem in primary health care settings that is difficult to treat. Two common treatments are mental relaxation and massage. Scientific studies show contradictory results. Many studies lack long-term follow-up even though it is a chronic disorder. The purpose of this randomized clinical trial was to assess possible effects of massage as compared to listening to relaxation tapes in conditions of ''diffuse'' and long-term musculoskeletal pain. 129 patients from primary health care suffering from long-term musculoskeletal pain were randomized to either a massage or mental relaxation group and assessed before during and after treatment. During treatment there was a significant improvement in the three main outcome measures: self-rated health mental energy and muscle pain only in the massage group as compared to the relaxation group. However at the 3-month post-treatment follow-up there was a significant worsening in the outcome measures back to initial rating levels in the massage group as compared to no changes in the relaxation group. Massage but not mental relaxation is beneficial in attenuating diffuse musculoskeletal symptoms. Beneficial effects were registered only during treatment. (PsycINFO Database Record (c) 2012 APA all rights reserved)
Keywords Mental relaxation
Power Yes, power achieved
Power1 Yes, using mental energy and muscle pain scales as outcome measures, the sample yielded a ß of 0.10 (Power.90), using an alpha of 0.05, for detecting a 15% difference between study groups.
Provider Type Physiotherapist
Intervention Description: Number Assigned (Dropout Rate) Massage: ND (ND); Mental relaxation (Active Control): ND (ND).
# Assigned (Dropout Rate)_ ND (ND); ND (ND).
double check # assign
Intervention Description: Dosages Massage: 6-10 x 30 mins, 1-3x/w, ND + ND; Mental relaxation (Active Control): ND x ND, 2x/w, 5w + ND.
Intervention Description: Dosages1 6-10 x 30 mins, 1-3x/w, ND + ND; ND x ND, 2x/w, 5w + ND.
*Meta-Analysis Yes
Relevant Results _ *Muscle Pain Scale (pain): p < 0.01 (between groups) over time, Effect Size = 0.48, Active Control, pre / post; Mental Energy Scale (mental and cognitive well-being): p < 0.01 (between groups) over time; Self-rated Health (health status): p < 0.03 (between groups) over time.
Conclusions Massage effective for: Pain, Quality of Life.
Adverse Events Authors do not report or mention anything about AEs
PubMed Link http://www.ncbi.nlm.nih.gov/pubmed/?term=hasson+A+Randomized+Clinical+Trial+of+the+Treatment+Effects+of+Massage+Compared+to+Relaxation+Tape+Recordings+on+Diffuse+Long-Term+Pain
27 1428 Hernandez-Reif, 2001* M. Hernandez-Reif, T. Field, J. Krasnegor and H. Theakston Lower back pain is reduced and range of motion increased after massage therapy 2001 Int J Neurosci vol 106 vol 106 pages 131-45 Group 1 pages 131-45 Int J Neurosci, vol 106: 3-4, pages 131-45 Musculoskeletal Pain: Low back pain 24 (11M/13F) participants with low back pain (mean age = 40 ± 14.9 yrs) Visual Analog Scale (pain) McGill Pain Questionnaire Short Form (pain) Range of Motion (Range of Motion) Visual Analog Scale (sleep disturbance) Visual Analog Scale (sleep effectiveness) Visual Analog Scale (sleep supplementary) Profile of Mood States Depression Scale (depression) State-Trait Anxiety Inventory (anxiety) Symptom Checklist-90 Revised (depression) Symptom Checklist-90 Revised (anxiety) Symptom Checklist-90 Revised (hostility) Urine sample (norepinephrine) Urine sample (epinephrine) Urine sample (dopamine) Urine sample (serotonin) Pain: Visual Analog Scale, McGill Pain Questionnaire Short Form. Activity: Range of Motion; Sleep: Visual Analog Scale; Mood: Profile of Mood States Depression Scale, State-Trait Anxiety Inventory, Symptom Checklist-90 Revised; Physiological: Cortiso 24 3-Low STUDY DESIGN: A randomized between-groups design evaluated massage therapy versus relaxation for chronic low back pain. OBJECTIVES: Treatment effects were evaluated for reducing pain depression anxiety and stress hormones and sleeplessness and for improving trunk range of motion associated with chronic low back pain. SUMMARY of BACKGROUND DATA: Twenty-four adults (M age=39.6 years) with low back pain of nociceptive origin with a duration of at least 6 months participated in the study. The groups did not differ on age socioeconomic status ethnicity or gender. METHODS: Twenty-four adults (12 women) with lower back pain were randomly assigned to a massage therapy or a progressive muscle relaxation group. Sessions were 30 minutes long twice a week for five weeks. On the first and last day of the 5-week study participants completed questionnaires provided a urine sample and were assessed for range of motion. RESULTS: By the end of the study the massage therapy group as compared to the relaxation group reported experiencing less pain depression anxiety and improved sleep. They also showed improved trunk and pain flexion performance and their serotonin and dopamine levels were higher. CONCLUSIONS: Massage therapy is effective in reducing pain stress hormones and symptoms associated with chronic low back pain. PRECIS: Adults (M age=39.6 years) with low back pain with a duration of at least 6 months received two 30-min massage or relaxation therapy sessions per week for 5 weeks. Participants receiving massage therapy reported experiencing less pain depression anxiety and their sleep had improved. They also showed improved trunk and pain flexion performance and their serotonin and dopamine levels were higher. Adult Not Described ND Massage therapist Massage Therapy: 12 (ND); Relaxation therapy (Active Control): 12 (ND). 12 (ND); 12 (ND). Massage Therapy: 10 x 30 mins, 2x/w, 5w + ND; Relaxation therapy (Active Control): ND. 10 x 30 mins, 2x/w, 5w + ND; ND. Yes *Visual Analog Scale (pain): p < 0.05 (within groups) (Massage Therapy) at 1d post and last day post, p = Not Significant (within groups) (Active Control) at all time points, Effect Size = -0.97, Active Control, pre / post; McGill Pain Questionnaire Short Form (pain): p < 0.005 (within groups) (Massage Therapy) at all time points, p < 0.05 (within groups) (Active Control) at 1d post and last day pre; *Range of Motion (Range of Motion): p < 0.05 (within groups) (Massage Therapy) at 1d post and last day pre, p = Not Significant (within groups) (Active Control) at all time points, Effect Size = -0.97, Active Control, pre / post; Visual Analog Scale (sleep disturbance): p = 0.05 (within groups) (Massage Therapy) at last day, p = Not Significant (within groups) (Active Control) at all time points; Visual Analog Scale (sleep effectiveness): p = Not Significant (within groups) (both groups) at all time points; Visual Analog Scale (sleep supplementary): p = Not Significant (within groups) (both groups) at all time points; Profile of Mood States Depression Scale (depression): p < 0.05 (within groups) (Massage Therapy) at 1d post and last day pre, p = 0.05 (within groups) (Active Control) at last day post; *State-Trait Anxiety Inventory (anxiety): p < 0.05 (within groups) (both groups) at 1d post, p = 0.05 (within groups) (both groups) at last day post; Symptom Checklist-90 Revised (depression): p = 0.05 (within groups) (both groups) at last day; Symptom Checklist-90 Revised (anxiety): p = Not Significant (within groups) (both groups) at all time points; Symptom Checklist-90 Revised (hostility): p = Not Significant (within groups) (both groups) at all time points; Urine sample (cortisol): p = Not Significant (within groups) (both groups) at all time points; Urine sample (norepinephrine): p = Not Significant (within groups) (both groups) at all time points; Urine sample (epinephrine): p = Not Significant (within groups) (both groups) at all time points; Urine sample (dopamine): p = 0.05 (within groups) (Massage Therapy) at last day, p = Not Significant (within groups) (Active Control) at all time points; Urine sample (serotonin): p = 0.05 (within groups) (Massage Therapy) at last day, p = Not Significant (within groups) (Active Control) at all time points. Massage effective for: Pain, Activity, Sleep, Mood, Physiological. Authors do not report or mention anything about AEs http://www.ncbi.nlm.nih.gov/pubmed/?term=hernandez+Lower+back+pain+is+reduced+and+range+of+motion+increased+after+massage+therapy
F1 27
Refid 1428
Quick Author Hernandez-Reif, 2001*
Author M. Hernandez-Reif, T. Field, J. Krasnegor and H. Theakston
Title Lower back pain is reduced and range of motion increased after massage therapy
Publication Date 2001
Periodical Int J Neurosci
F8 vol
Volume 106
F10 vol 106
Issue
F12 pages
Page Start-End 131-45
Group Group 1
F15 pages 131-45
Publication Data Int J Neurosci, vol 106: 3-4, pages 131-45
Condition Musculoskeletal Pain: Low back pain
Condition (to hide) 24 (11M/13F) participants with low back pain (mean age = 40 ± 14.9 yrs)
Outcome Measures
cleaned up results Visual Analog Scale (pain) McGill Pain Questionnaire Short Form (pain) Range of Motion (Range of Motion) Visual Analog Scale (sleep disturbance) Visual Analog Scale (sleep effectiveness) Visual Analog Scale (sleep supplementary) Profile of Mood States Depression Scale (depression) State-Trait Anxiety Inventory (anxiety) Symptom Checklist-90 Revised (depression) Symptom Checklist-90 Revised (anxiety) Symptom Checklist-90 Revised (hostility) Urine sample (norepinephrine) Urine sample (epinephrine) Urine sample (dopamine) Urine sample (serotonin)
Outcome Measures_ Pain: Visual Analog Scale, McGill Pain Questionnaire Short Form. Activity: Range of Motion; Sleep: Visual Analog Scale; Mood: Profile of Mood States Depression Scale, State-Trait Anxiety Inventory, Symptom Checklist-90 Revised; Physiological: Cortiso
Total Participants 24
Quality Assignment (SIGN 50) 3-Low
Abstract STUDY DESIGN: A randomized between-groups design evaluated massage therapy versus relaxation for chronic low back pain. OBJECTIVES: Treatment effects were evaluated for reducing pain depression anxiety and stress hormones and sleeplessness and for improving trunk range of motion associated with chronic low back pain. SUMMARY of BACKGROUND DATA: Twenty-four adults (M age=39.6 years) with low back pain of nociceptive origin with a duration of at least 6 months participated in the study. The groups did not differ on age socioeconomic status ethnicity or gender. METHODS: Twenty-four adults (12 women) with lower back pain were randomly assigned to a massage therapy or a progressive muscle relaxation group. Sessions were 30 minutes long twice a week for five weeks. On the first and last day of the 5-week study participants completed questionnaires provided a urine sample and were assessed for range of motion. RESULTS: By the end of the study the massage therapy group as compared to the relaxation group reported experiencing less pain depression anxiety and improved sleep. They also showed improved trunk and pain flexion performance and their serotonin and dopamine levels were higher. CONCLUSIONS: Massage therapy is effective in reducing pain stress hormones and symptoms associated with chronic low back pain. PRECIS: Adults (M age=39.6 years) with low back pain with a duration of at least 6 months received two 30-min massage or relaxation therapy sessions per week for 5 weeks. Participants receiving massage therapy reported experiencing less pain depression anxiety and their sleep had improved. They also showed improved trunk and pain flexion performance and their serotonin and dopamine levels were higher.
Keywords Adult
Power Not Described
Power1 ND
Provider Type Massage therapist
Intervention Description: Number Assigned (Dropout Rate) Massage Therapy: 12 (ND); Relaxation therapy (Active Control): 12 (ND).
# Assigned (Dropout Rate)_ 12 (ND); 12 (ND).
double check # assign
Intervention Description: Dosages Massage Therapy: 10 x 30 mins, 2x/w, 5w + ND; Relaxation therapy (Active Control): ND.
Intervention Description: Dosages1 10 x 30 mins, 2x/w, 5w + ND; ND.
*Meta-Analysis Yes
Relevant Results _ *Visual Analog Scale (pain): p < 0.05 (within groups) (Massage Therapy) at 1d post and last day post, p = Not Significant (within groups) (Active Control) at all time points, Effect Size = -0.97, Active Control, pre / post; McGill Pain Questionnaire Short Form (pain): p < 0.005 (within groups) (Massage Therapy) at all time points, p < 0.05 (within groups) (Active Control) at 1d post and last day pre; *Range of Motion (Range of Motion): p < 0.05 (within groups) (Massage Therapy) at 1d post and last day pre, p = Not Significant (within groups) (Active Control) at all time points, Effect Size = -0.97, Active Control, pre / post; Visual Analog Scale (sleep disturbance): p = 0.05 (within groups) (Massage Therapy) at last day, p = Not Significant (within groups) (Active Control) at all time points; Visual Analog Scale (sleep effectiveness): p = Not Significant (within groups) (both groups) at all time points; Visual Analog Scale (sleep supplementary): p = Not Significant (within groups) (both groups) at all time points; Profile of Mood States Depression Scale (depression): p < 0.05 (within groups) (Massage Therapy) at 1d post and last day pre, p = 0.05 (within groups) (Active Control) at last day post; *State-Trait Anxiety Inventory (anxiety): p < 0.05 (within groups) (both groups) at 1d post, p = 0.05 (within groups) (both groups) at last day post; Symptom Checklist-90 Revised (depression): p = 0.05 (within groups) (both groups) at last day; Symptom Checklist-90 Revised (anxiety): p = Not Significant (within groups) (both groups) at all time points; Symptom Checklist-90 Revised (hostility): p = Not Significant (within groups) (both groups) at all time points; Urine sample (cortisol): p = Not Significant (within groups) (both groups) at all time points; Urine sample (norepinephrine): p = Not Significant (within groups) (both groups) at all time points; Urine sample (epinephrine): p = Not Significant (within groups) (both groups) at all time points; Urine sample (dopamine): p = 0.05 (within groups) (Massage Therapy) at last day, p = Not Significant (within groups) (Active Control) at all time points; Urine sample (serotonin): p = 0.05 (within groups) (Massage Therapy) at last day, p = Not Significant (within groups) (Active Control) at all time points.
Conclusions Massage effective for: Pain, Activity, Sleep, Mood, Physiological.
Adverse Events Authors do not report or mention anything about AEs
PubMed Link http://www.ncbi.nlm.nih.gov/pubmed/?term=hernandez+Lower+back+pain+is+reduced+and+range+of+motion+increased+after+massage+therapy
28 1429 Hernandez-Reif, 2000 M. Hernandez-Reif, A. Martinez, T. Field, O. Quintero, S. Hart and I. Burman Premenstrual symptoms are relieved by massage therapy 2000 J Psychosom Obstet Gynaecol vol 21 vol 21 1 pages 9-15 Group 3 pages 9-15 J Psychosom Obstet Gynaecol, vol 21: 1, pages 9-15 Visceral Pain: Premenstrual dysphoric disorder 24 females with premenstrual dysphoric disorder (mean age = 33 yrs) Visual Analog Scale (pain) State-Trait Anxiety Inventory (anxiety) Profile of Mood States (depression) Center for Epidemiological Studies Depression Scale (depression) Menstrual Distress Questionnaire (distress) Pain: Visual Analog Scale; Mood: State-Trait Anxiety Inventory, Profile of Mood States, Center for Epidemiological Studies Depression Scale; Stress: Menstrual Distress Questionnaire. 24 2-Acceptable Twenty-four women meeting Diagnostic and Statistical Manual of Mental Disorders (4th edn; DSM-IV) criteria for premenstrual dysphoric disorder (PDD) were randomly assigned to a massage therapy or a relaxation therapy group. The massage group showed decreases in anxiety depressed mood and pain immediately after the first and last massage sessions. The longer term (5 week) effects of massage therapy included a reduction in pain and water retention and overall menstrual distress. However no long-term changes were observed in the massaged group's activity level or mood. Future studies might examine the effects of a longer massage therapy program on these symptoms. Overall the findings from this study suggest that massage therapy may be an effective adjunct therapy for treating severe premenstrual symptoms. Adult Not Described ND Therapist (type not specified) Massage Therapy: ND (ND); Relaxation Therapy (Active Control): ND (ND). ND (ND); ND (ND). Massage Therapy: 10 x 30 mins, 2x/w, 5w + ND; Relaxation Therapy (Active Control): ND x 30 mins, ND, ND + ND. 10 x 30 mins, 2x/w, 5w + ND; ND x 30 mins, ND, ND + ND. No Visual Analog Scale (pain): p = 0.05 (within groups) (Massage Therapy) at post 1d and last day, p = Not Significant (within groups) (Active Control) at post 1d and last day, Effect Size = -0.76, pre / post; State-Trait Anxiety Inventory (anxiety): p < 0.05 (within groups) (Massage Therapy) at post 1d and last day, p = 0.05 (within groups) (Active Control) at post 1d and p = Not Significant (within groups) at post last day; Profile of Mood States (depression): p < 0.05 (within groups) (Massage Therapy) at post 1d and last day, p = Not Significant (within groups) (Active Control) post first and last day; Center for Epidemiological Studies Depression Scale (depression): p = Not Significant (within groups) (both groups) at post 1d and last day; Menstrual Distress Questionnaire (distress): p < 0.05 (within groups) (massage) at post 1d and last day. Massage effective for: Pain, Mood, Stress. Authors do not report or mention anything about AEs http://www.ncbi.nlm.nih.gov/pubmed/?term=hernandez++Premenstrual+symptoms+are+relieved+by+massage+therapy
F1 28
Refid 1429
Quick Author Hernandez-Reif, 2000
Author M. Hernandez-Reif, A. Martinez, T. Field, O. Quintero, S. Hart and I. Burman
Title Premenstrual symptoms are relieved by massage therapy
Publication Date 2000
Periodical J Psychosom Obstet Gynaecol
F8 vol
Volume 21
F10 vol 21
Issue 1
F12 pages
Page Start-End 9-15
Group Group 3
F15 pages 9-15
Publication Data J Psychosom Obstet Gynaecol, vol 21: 1, pages 9-15
Condition Visceral Pain: Premenstrual dysphoric disorder
Condition (to hide) 24 females with premenstrual dysphoric disorder (mean age = 33 yrs)
Outcome Measures
cleaned up results Visual Analog Scale (pain) State-Trait Anxiety Inventory (anxiety) Profile of Mood States (depression) Center for Epidemiological Studies Depression Scale (depression) Menstrual Distress Questionnaire (distress)
Outcome Measures_ Pain: Visual Analog Scale; Mood: State-Trait Anxiety Inventory, Profile of Mood States, Center for Epidemiological Studies Depression Scale; Stress: Menstrual Distress Questionnaire.
Total Participants 24
Quality Assignment (SIGN 50) 2-Acceptable
Abstract Twenty-four women meeting Diagnostic and Statistical Manual of Mental Disorders (4th edn; DSM-IV) criteria for premenstrual dysphoric disorder (PDD) were randomly assigned to a massage therapy or a relaxation therapy group. The massage group showed decreases in anxiety depressed mood and pain immediately after the first and last massage sessions. The longer term (5 week) effects of massage therapy included a reduction in pain and water retention and overall menstrual distress. However no long-term changes were observed in the massaged group's activity level or mood. Future studies might examine the effects of a longer massage therapy program on these symptoms. Overall the findings from this study suggest that massage therapy may be an effective adjunct therapy for treating severe premenstrual symptoms.
Keywords Adult
Power Not Described
Power1 ND
Provider Type Therapist (type not specified)
Intervention Description: Number Assigned (Dropout Rate) Massage Therapy: ND (ND); Relaxation Therapy (Active Control): ND (ND).
# Assigned (Dropout Rate)_ ND (ND); ND (ND).
double check # assign
Intervention Description: Dosages Massage Therapy: 10 x 30 mins, 2x/w, 5w + ND; Relaxation Therapy (Active Control): ND x 30 mins, ND, ND + ND.
Intervention Description: Dosages1 10 x 30 mins, 2x/w, 5w + ND; ND x 30 mins, ND, ND + ND.
*Meta-Analysis No
Relevant Results _ Visual Analog Scale (pain): p = 0.05 (within groups) (Massage Therapy) at post 1d and last day, p = Not Significant (within groups) (Active Control) at post 1d and last day, Effect Size = -0.76, pre / post; State-Trait Anxiety Inventory (anxiety): p < 0.05 (within groups) (Massage Therapy) at post 1d and last day, p = 0.05 (within groups) (Active Control) at post 1d and p = Not Significant (within groups) at post last day; Profile of Mood States (depression): p < 0.05 (within groups) (Massage Therapy) at post 1d and last day, p = Not Significant (within groups) (Active Control) post first and last day; Center for Epidemiological Studies Depression Scale (depression): p = Not Significant (within groups) (both groups) at post 1d and last day; Menstrual Distress Questionnaire (distress): p < 0.05 (within groups) (massage) at post 1d and last day.
Conclusions Massage effective for: Pain, Mood, Stress.
Adverse Events Authors do not report or mention anything about AEs
PubMed Link http://www.ncbi.nlm.nih.gov/pubmed/?term=hernandez++Premenstrual+symptoms+are+relieved+by+massage+therapy
29 1452 Hoehler, 1981 F. K. Hoehler, J. S. Tobis and A. A. Buerger Spinal manipulation for low back pain 1981 Jama vol 245 vol 245 18 pages 1835-8 Group 1 pages 1835-8 Jama, vol 245: 18, pages 1835-8 Musculoskeletal Pain: Low back pain 95c (56M/39F) participants with low back pain (mean age = 31 ± 9.1 yrs) Ordinal Scale (pain) Ordinal Scale (straight-leg raising to pain) Ordinal Scale (straight-leg raising to pelvic rotation) Ordinal Scale (distance of fingertips from the floor on maximum forward flexion) Ordinal Scale (walking) Ordinal Scale (bending or twisting) Ordinal Scale (sitting down in a chair) Ordinal Scale (sitting up in bed) Ordinal Scale (reaching) Ordinal Scale (dressing) Pain: Ordinal Scale; Activity: Ordinal Scale 95 3-Low A randomized clinical trial of rotational manipulation was conducted on 95 patients with low back pain selected for (1) the absence of any contraindications for vertebral manipulation (2) the absence of any psychosocial problems that might affect the outcome of treatment (3) the absence of any previous experience with manipulative therapy and (4) the presence of palpatory cues indicating that manipulation might be successful. Patients were randomly assigned to one of two groups: an experimental group receiving manipulation therapy and a control group receiving soft-tissue massage. Comparison of the two groups indicated that (1) patients who received manipulative treatment were much more likely to report immediate relief after the first treatment and (2) at discharge there was no significant difference between the two groups because both showed substantial improvement. Adult Not Described ND Physician Soft-tissue Massage: 39 (28%); Manipulation Therapy: 56 (27%). 39 (28%); 56 (27%). Soft-tissue Massage: ND; Manipulation Therapy: ND. ND; ND. No Ordinal Scale (pain): p < 0.05 (within groups) (manipulation), p < 0.05 (within groups) (massage) over time, p < 0.05 (between groups) at post; Ordinal Scale (straight-leg raising to pain): p < 0.01 (between groups) at post; Ordinal Scale (straight-leg raising to pelvic rotation): p = Not Significant (between groups) at post; Ordinal Scale (distance of fingertips from the floor on maximum forward flexion): p = Not Described; Ordinal Scale (walking): p = Not Significant (between groups) at post; Ordinal Scale (bending or twisting): p = Not Significant (between groups) at post; Ordinal Scale (sitting down in a chair): p < 0.01 (between groups) at post; Ordinal Scale (sitting up in bed): p < 0.01 (between groups) at post; Ordinal Scale (reaching): p < 0.05 (within groups) (massage) over time, p < 0.01 (between groups) at post; Ordinal Scale (dressing): p < 0.01 (between groups) at post. Massage effective for: Pain, Activity. Authors do not report or mention anything about AEs http://www.ncbi.nlm.nih.gov/pubmed/6453240
F1 29
Refid 1452
Quick Author Hoehler, 1981
Author F. K. Hoehler, J. S. Tobis and A. A. Buerger
Title Spinal manipulation for low back pain
Publication Date 1981
Periodical Jama
F8 vol
Volume 245
F10 vol 245
Issue 18
F12 pages
Page Start-End 1835-8
Group Group 1
F15 pages 1835-8
Publication Data Jama, vol 245: 18, pages 1835-8
Condition Musculoskeletal Pain: Low back pain
Condition (to hide) 95c (56M/39F) participants with low back pain (mean age = 31 ± 9.1 yrs)
Outcome Measures
cleaned up results Ordinal Scale (pain) Ordinal Scale (straight-leg raising to pain) Ordinal Scale (straight-leg raising to pelvic rotation) Ordinal Scale (distance of fingertips from the floor on maximum forward flexion) Ordinal Scale (walking) Ordinal Scale (bending or twisting) Ordinal Scale (sitting down in a chair) Ordinal Scale (sitting up in bed) Ordinal Scale (reaching) Ordinal Scale (dressing)
Outcome Measures_ Pain: Ordinal Scale; Activity: Ordinal Scale
Total Participants 95
Quality Assignment (SIGN 50) 3-Low
Abstract A randomized clinical trial of rotational manipulation was conducted on 95 patients with low back pain selected for (1) the absence of any contraindications for vertebral manipulation (2) the absence of any psychosocial problems that might affect the outcome of treatment (3) the absence of any previous experience with manipulative therapy and (4) the presence of palpatory cues indicating that manipulation might be successful. Patients were randomly assigned to one of two groups: an experimental group receiving manipulation therapy and a control group receiving soft-tissue massage. Comparison of the two groups indicated that (1) patients who received manipulative treatment were much more likely to report immediate relief after the first treatment and (2) at discharge there was no significant difference between the two groups because both showed substantial improvement.
Keywords Adult
Power Not Described
Power1 ND
Provider Type Physician
Intervention Description: Number Assigned (Dropout Rate) Soft-tissue Massage: 39 (28%); Manipulation Therapy: 56 (27%).
# Assigned (Dropout Rate)_ 39 (28%); 56 (27%).
double check # assign
Intervention Description: Dosages Soft-tissue Massage: ND; Manipulation Therapy: ND.
Intervention Description: Dosages1 ND; ND.
*Meta-Analysis No
Relevant Results _ Ordinal Scale (pain): p < 0.05 (within groups) (manipulation), p < 0.05 (within groups) (massage) over time, p < 0.05 (between groups) at post; Ordinal Scale (straight-leg raising to pain): p < 0.01 (between groups) at post; Ordinal Scale (straight-leg raising to pelvic rotation): p = Not Significant (between groups) at post; Ordinal Scale (distance of fingertips from the floor on maximum forward flexion): p = Not Described; Ordinal Scale (walking): p = Not Significant (between groups) at post; Ordinal Scale (bending or twisting): p = Not Significant (between groups) at post; Ordinal Scale (sitting down in a chair): p < 0.01 (between groups) at post; Ordinal Scale (sitting up in bed): p < 0.01 (between groups) at post; Ordinal Scale (reaching): p < 0.05 (within groups) (massage) over time, p < 0.01 (between groups) at post; Ordinal Scale (dressing): p < 0.01 (between groups) at post.
Conclusions Massage effective for: Pain, Activity.
Adverse Events Authors do not report or mention anything about AEs
PubMed Link http://www.ncbi.nlm.nih.gov/pubmed/6453240
30 1488 Hou, 2002 C. R. Hou, L. C. Tsai, K. F. Cheng, K. C. Chung and C. Z. Hong Immediate effects of various physical therapeutic modalities on cervical myofascial pain and trigger-point sensitivity 2002 Arch Phys Med Rehabil vol 83 vol 83 10 pages 1406-14 Group 1 pages 1406-14 Arch Phys Med Rehabil, vol 83: 10, pages 1406-14 Musculoskeletal Pain: Cervical myofascial pain 119c (12M/107 F) participants with cervical myofascial pain (mean age = 47 ± 13.4 yrs) Visual Analog Scale (pain) Cervical Range of Motion (Range of Motion) Pain Pressure Threshold meter (minimum applied force on muscle that induces discomfort or pain) Pain Pressure Threshold meter (maximum force a person can tolerate) Pain: Visual Analog Scale; Activity: Cervical Range of Motion; Pain Pressure Threshold: Pain Pressure Threshold meter. 119 2-Acceptable OBJECTIVE: To investigate the immediate effect of physical therapeutic modalities on myofascial pain in the upper trapezius muscle. DESIGN: Randomized controlled trial. SETTING: Institutional practice. PATIENTS: One hundred nineteen subjects with palpably active myofascial trigger points (MTrPs). INTERVENTION: Stage 1 evaluated the immediate effect of ischemic compression including 2 treatment pressures (P1 pain threshold; P2 averaged pain threshold and tolerance) and 3 durations (T1 30s; T2 60s; T3 90s). Stage 2 evaluated 6 therapeutics combinations including groups B1 (hot pack plus active range of motion [ROM]) B2 (B1 plus ischemic compression) B3 (B2 plus transcutaneous electric nerve stimulation [TENS]) B4 (B1 plus stretch with spray) B5 (B4 plus TENS) and B6 (B1 plus interferential current and myofascial release). MAIN OUTCOME MEASURES: The indexes of changes in pain threshold (IThC) pain tolerance (IToC) visual analog scale (IVC) and ROM (IRC) were evaluated for treatment effect. RESULTS: In stage 1 the IThC IToC IVC and IRC were significantly improved in the groups P1T3 P2T2 and P2T3 compared with the P1T1 and P1T2 treatments (P<.05). In stage 2 groups B3 B5 and B6 showed significant improvement in IThC ItoC and IVC compared with the B1 group; groups B4 B5 and B6 showed significant improvement in IRC compared with group B1 (P<.05). CONCLUSIONS: Ischemic compression therapy provides alternative treatments using either low pressure (pain threshold) and a long duration (90s) or high pressure (the average of pain threshold and pain tolerance) and short duration (30s) for immediate pain relief and MTrP sensitivity suppression. Results suggest that therapeutic combinations such as hot pack plus active ROM and stretch with spray hot pack plus active ROM and stretch with spray as well as TENS and hot pack plus active ROM and interferential current as well as myofascial release technique are most effective for easing MTrP pain and increasing cervical ROM. Adult Yes, power achieved Yes, The determined sample size of MTrPs and subject number in each group were based on statistical power analysis. Physical therapist 30 sec. pain threshold (P1T1): 8 (0%); 60 sec. pain threshold (P1T2): 8 (0%); 90 sec. pain threshold (P1T3): 8 (0%); 30 sec. avg pain threshold / tolerance (P2T1): 8 (0%); 60 sec. avg pain threshold / tolerance (P2T2): 8 (0%); 90 sec. avg pain threshold / 8 (0%); 8 (0%); 8 (0%); 8 (0%); 8 (0%); 8 (0%); 21 (0%); 13 (0%); 9 (0%); 10 (0%); 9 (0%); 9 (0%). 30 sec. pain threshold (P1T1): 1 x ND, 1x, 1d + ND; 60 sec. pain threshold (P1T2): 1 x ND, 1x, 1d + ND; 90 sec. pain threshold (P1T3): 1 x ND, 1x, 1d + ND; 30 sec. avg pain threshold / tolerance (P2T1): 1 x ND, 1x, 1d + ND; 60 sec. avg pain threshold / to 1 x ND, 1x, 1d + ND; 1 x ND, 1x, 1d + ND; 1 x ND, 1x, 1d + ND; 1 x ND, 1x, 1d + ND; 1 x ND, 1x, 1d + ND; 1 x ND, 1x, 1d + ND; 1 x ND, 1x, 1d + ND; 1 x 40 mins, 1x, 1d + ND; 1 x ND, 1x, 1d + ND; 1 x 40 mins, 1x, 1d + ND; 1 x ND, 1x, 1d + ND; 1 x 20 mins, 1 No Visual Analog Scale (pain): p < 0.05 (within groups) (P1T1, P1T2, P1T3, P2T1, P2T2, P2T3, B1, B2, B3, B4, B5, B6) at post; Cervical Range of Motion (Range of Motion): p < 0.05 (within groups) (P1T3, P2T1, P2T2, P2T3, B4, B5, B6) at post; Pain Pressure Threshold meter (minimum applied force on muscle that induces discomfort or pain): p < 0.05 (within groups) (P1T3, P2T1, P2T2, P2T3, B1, B2, B3, B4, B5, B6) at post, p < 0.05 (between groups) (B3, B1), (B5, B1), (B6, B1), (B6, B2) at post; Pain Pressure Threshold meter (maximum force a person can tolerate): p < 0.05 (within groups) (P1T3, P2T1, P2T2, P2T3, B1, B2, B3, B4, B5, B6) at post, p < 0.05 (between groups) (B3 / B1), (B5 / B1), (B5 / B2), (B6 / B1), (B6 / B2) at post. Massage effective for: Pain, Activity, Pain Pressure Threshold. Authors do not report or mention anything about AEs http://www.ncbi.nlm.nih.gov/pubmed/?term=hou++Immediate+effects+of+various+physical+therapeutic+modalities+on+cervical+myofascial+pain+and+trigger-point+sensitivity
F1 30
Refid 1488
Quick Author Hou, 2002
Author C. R. Hou, L. C. Tsai, K. F. Cheng, K. C. Chung and C. Z. Hong
Title Immediate effects of various physical therapeutic modalities on cervical myofascial pain and trigger-point sensitivity
Publication Date 2002
Periodical Arch Phys Med Rehabil
F8 vol
Volume 83
F10 vol 83
Issue 10
F12 pages
Page Start-End 1406-14
Group Group 1
F15 pages 1406-14
Publication Data Arch Phys Med Rehabil, vol 83: 10, pages 1406-14
Condition Musculoskeletal Pain: Cervical myofascial pain
Condition (to hide) 119c (12M/107 F) participants with cervical myofascial pain (mean age = 47 ± 13.4 yrs)
Outcome Measures
cleaned up results Visual Analog Scale (pain) Cervical Range of Motion (Range of Motion) Pain Pressure Threshold meter (minimum applied force on muscle that induces discomfort or pain) Pain Pressure Threshold meter (maximum force a person can tolerate)
Outcome Measures_ Pain: Visual Analog Scale; Activity: Cervical Range of Motion; Pain Pressure Threshold: Pain Pressure Threshold meter.
Total Participants 119
Quality Assignment (SIGN 50) 2-Acceptable
Abstract OBJECTIVE: To investigate the immediate effect of physical therapeutic modalities on myofascial pain in the upper trapezius muscle. DESIGN: Randomized controlled trial. SETTING: Institutional practice. PATIENTS: One hundred nineteen subjects with palpably active myofascial trigger points (MTrPs). INTERVENTION: Stage 1 evaluated the immediate effect of ischemic compression including 2 treatment pressures (P1 pain threshold; P2 averaged pain threshold and tolerance) and 3 durations (T1 30s; T2 60s; T3 90s). Stage 2 evaluated 6 therapeutics combinations including groups B1 (hot pack plus active range of motion [ROM]) B2 (B1 plus ischemic compression) B3 (B2 plus transcutaneous electric nerve stimulation [TENS]) B4 (B1 plus stretch with spray) B5 (B4 plus TENS) and B6 (B1 plus interferential current and myofascial release). MAIN OUTCOME MEASURES: The indexes of changes in pain threshold (IThC) pain tolerance (IToC) visual analog scale (IVC) and ROM (IRC) were evaluated for treatment effect. RESULTS: In stage 1 the IThC IToC IVC and IRC were significantly improved in the groups P1T3 P2T2 and P2T3 compared with the P1T1 and P1T2 treatments (P<.05). In stage 2 groups B3 B5 and B6 showed significant improvement in IThC ItoC and IVC compared with the B1 group; groups B4 B5 and B6 showed significant improvement in IRC compared with group B1 (P<.05). CONCLUSIONS: Ischemic compression therapy provides alternative treatments using either low pressure (pain threshold) and a long duration (90s) or high pressure (the average of pain threshold and pain tolerance) and short duration (30s) for immediate pain relief and MTrP sensitivity suppression. Results suggest that therapeutic combinations such as hot pack plus active ROM and stretch with spray hot pack plus active ROM and stretch with spray as well as TENS and hot pack plus active ROM and interferential current as well as myofascial release technique are most effective for easing MTrP pain and increasing cervical ROM.
Keywords Adult
Power Yes, power achieved
Power1 Yes, The determined sample size of MTrPs and subject number in each group were based on statistical power analysis.
Provider Type Physical therapist
Intervention Description: Number Assigned (Dropout Rate) 30 sec. pain threshold (P1T1): 8 (0%); 60 sec. pain threshold (P1T2): 8 (0%); 90 sec. pain threshold (P1T3): 8 (0%); 30 sec. avg pain threshold / tolerance (P2T1): 8 (0%); 60 sec. avg pain threshold / tolerance (P2T2): 8 (0%); 90 sec. avg pain threshold /
# Assigned (Dropout Rate)_ 8 (0%); 8 (0%); 8 (0%); 8 (0%); 8 (0%); 8 (0%); 21 (0%); 13 (0%); 9 (0%); 10 (0%); 9 (0%); 9 (0%).
double check # assign
Intervention Description: Dosages 30 sec. pain threshold (P1T1): 1 x ND, 1x, 1d + ND; 60 sec. pain threshold (P1T2): 1 x ND, 1x, 1d + ND; 90 sec. pain threshold (P1T3): 1 x ND, 1x, 1d + ND; 30 sec. avg pain threshold / tolerance (P2T1): 1 x ND, 1x, 1d + ND; 60 sec. avg pain threshold / to
Intervention Description: Dosages1 1 x ND, 1x, 1d + ND; 1 x ND, 1x, 1d + ND; 1 x ND, 1x, 1d + ND; 1 x ND, 1x, 1d + ND; 1 x ND, 1x, 1d + ND; 1 x ND, 1x, 1d + ND; 1 x ND, 1x, 1d + ND; 1 x 40 mins, 1x, 1d + ND; 1 x ND, 1x, 1d + ND; 1 x 40 mins, 1x, 1d + ND; 1 x ND, 1x, 1d + ND; 1 x 20 mins, 1
*Meta-Analysis No
Relevant Results _ Visual Analog Scale (pain): p < 0.05 (within groups) (P1T1, P1T2, P1T3, P2T1, P2T2, P2T3, B1, B2, B3, B4, B5, B6) at post; Cervical Range of Motion (Range of Motion): p < 0.05 (within groups) (P1T3, P2T1, P2T2, P2T3, B4, B5, B6) at post; Pain Pressure Threshold meter (minimum applied force on muscle that induces discomfort or pain): p < 0.05 (within groups) (P1T3, P2T1, P2T2, P2T3, B1, B2, B3, B4, B5, B6) at post, p < 0.05 (between groups) (B3, B1), (B5, B1), (B6, B1), (B6, B2) at post; Pain Pressure Threshold meter (maximum force a person can tolerate): p < 0.05 (within groups) (P1T3, P2T1, P2T2, P2T3, B1, B2, B3, B4, B5, B6) at post, p < 0.05 (between groups) (B3 / B1), (B5 / B1), (B5 / B2), (B6 / B1), (B6 / B2) at post.
Conclusions Massage effective for: Pain, Activity, Pain Pressure Threshold.
Adverse Events Authors do not report or mention anything about AEs
PubMed Link http://www.ncbi.nlm.nih.gov/pubmed/?term=hou++Immediate+effects+of+various+physical+therapeutic+modalities+on+cervical+myofascial+pain+and+trigger-point+sensitivity
1 2 3 4 5 6 7 8 9 10 11 12